Novo Nordisk Sues Eli Lilly Over Alleged Deceptive Weight Loss Drug Advertising - Novo Nordisk (NYSE:NVO)

Novo Nordisk sues Eli Lilly, accusing it of false advertising of weight-loss drug

Novo Nordisk has sued Eli Lilly in a U.S. court. The Danish company accuses Lilly of false advertising for its weight-loss medicines. Novo claims Lilly compared lower doses of its drugs with higher doses of Lilly's.…